Search details
1.
Reclassification of a likely pathogenic Dutch founder variant in KCNH2; implications of reduced penetrance.
Hum Mol Genet
; 32(7): 1072-1082, 2023 03 20.
Article
in English
| MEDLINE | ID: mdl-36269083
2.
Brugada syndrome in Japan and Europe: a genome-wide association study reveals shared genetic architecture and new risk loci.
Eur Heart J
; 2024 May 15.
Article
in English
| MEDLINE | ID: mdl-38747976
3.
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
Eur Heart J
; 45(7): 538-548, 2024 Feb 16.
Article
in English
| MEDLINE | ID: mdl-38195003
4.
Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation.
Circulation
; 147(21): 1622-1633, 2023 05 23.
Article
in English
| MEDLINE | ID: mdl-37216437
5.
Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).
Circulation
; 147(21): 1568-1578, 2023 05 23.
Article
in English
| MEDLINE | ID: mdl-36960730
6.
Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
Circulation
; 148(25): 2029-2037, 2023 12 19.
Article
in English
| MEDLINE | ID: mdl-37886885
7.
Insights into adherence to medication and lifestyle recommendations in an international cohort of patients with catecholaminergic polymorphic ventricular tachycardia.
Europace
; 26(2)2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38349347
8.
Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study.
Europace
; 26(4)2024 Mar 30.
Article
in English
| MEDLINE | ID: mdl-38558121
9.
Is it safe to give birth with an activated implantable cardioverter-defibrillator: A multicentre observational study.
BJOG
; 2024 Feb 07.
Article
in English
| MEDLINE | ID: mdl-38326282
10.
Use, misuse, and pitfalls of the drug challenge test in the diagnosis of the Brugada syndrome.
Eur Heart J
; 44(27): 2427-2439, 2023 Jul 14.
Article
in English
| MEDLINE | ID: mdl-37345279
11.
Prognosis and clinical management of asymptomatic family members with RYR2-mediated catecholaminergic polymorphic ventricular tachycardia: a review.
Cardiol Young
; : 1-8, 2024 Apr 24.
Article
in English
| MEDLINE | ID: mdl-38653721
12.
The Dutch Idiopathic Ventricular Fibrillation Registry: progress report on the quest to identify the unidentifiable.
Neth Heart J
; 2024 Apr 23.
Article
in English
| MEDLINE | ID: mdl-38653923
13.
Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of Cardiology.
Neth Heart J
; 32(5): 190-197, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38634993
14.
Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.
Circulation
; 146(19): 1434-1443, 2022 11 08.
Article
in English
| MEDLINE | ID: mdl-36205131
15.
Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
Circulation
; 145(5): 321-329, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34779221
16.
Subcutaneous or Transvenous Defibrillator Therapy.
N Engl J Med
; 383(6): 526-536, 2020 08 06.
Article
in English
| MEDLINE | ID: mdl-32757521
17.
Reduction in long-term mortality using remote device monitoring in a large real-world population of patients with implantable defibrillators.
Europace
; 25(3): 969-977, 2023 03 30.
Article
in English
| MEDLINE | ID: mdl-36636951
18.
Risk stratification of sudden cardiac death: a review.
Europace
; 25(8)2023 08 25.
Article
in English
| MEDLINE | ID: mdl-37622576
19.
RYR2-ryanodinopathies: from calcium overload to calcium deficiency.
Europace
; 25(6)2023 06 02.
Article
in English
| MEDLINE | ID: mdl-37387319
20.
Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement.
Europace
; 25(7)2023 07 04.
Article
in English
| MEDLINE | ID: mdl-37379530